Connect with us
Information

WORLD EDITION
Australia
North America
World

Investing News NetworkYour trusted source for investing success

WORLD EDITION
North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

Biotech Market
Biotech News
Biotech Stocks

Longboard Pharmaceuticals Inc.

NASDAQ:LBPH

Featured Articles and Interviews

Apr 22, 2025

Top 5 Canadian Biotech Stocks in 2025

More Featured Articles and Inverviews

Press Releases

Jun 10, 2024

Longboard Pharmaceuticals Announces Positive Interim Results from the Open-Label Extension of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies

May 06, 2024

Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635

May 02, 2024

Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates

More Press Releases

Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Its pipeline includes LP352, LP143, and LP659.

Go Deeper

AI Powered

Microscopic view of stem cells.

Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

Senior woman doing exercises alongside closeup of DNA.

5 US Longevity and Anti-aging Stocks to Watch in 2025

Interactive Chart

Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.